Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check7 days agoChange DetectedBolzano's location entry has been updated to Bolzano, Trentino-Alto Adige, Italy, 39100, replacing the previous Bolzano entry listed under Trentino-Sudtirol. This reflects a regional naming update and provides the same city/address in the study's locations.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new published version of the study details page.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Locations section updated the Bolzano entry: the region is now Trentino-Sudtirol (instead of Trentino-Alto Adige) and the listing reads Bolzano, Trentino-Sudtirol, Italy, 39100. This reflects a regional naming update and a more precise address for the site.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a new revision of the page metadata.SummaryDifference0.0%

- Check57 days agoChange DetectedNew study sites were added, including Taipei Veterans General Hospital (Site 1652), Taichung Veterans General Hospital (Site 1653), and China Medical University Hospital-Department of Urology (Site 1654), among others. The total number of locations is now listed as 209.SummaryDifference0.8%

- Check65 days agoChange DetectedRevision tag changed from v3.5.2 to v3.5.3. This update represents a revision history increment without modifying the information shown on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.